THE NKG2D SYSTEM MEDIATES ANTI-TUMOR EFFECTS OF CHEMOTHERAPY AND RADIOTHERAPY AGAINST GLIOBLASTOMA

被引：0
作者：
Weiss, T. [1 ,2 ,3 ]
Schneider, H. [1 ,2 ,3 ]
Silginer, M. [1 ,2 ,3 ]
Steinle, A. [4 ]
Pruschy, M. [3 ,5 ]
Weller, M. [1 ,2 ,3 ]
Roth, P. [1 ,2 ,3 ]
机构：
[1] Univ Hosp, Dept Neurol, Zurich, Switzerland
[2] Univ Hosp, Brain Tumor Ctr, Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Goethe Univ Frankfurt, Inst Mol Med, Frankfurt, Germany
[5] Univ Hosp, Dept Radiat Oncol, Zurich, Switzerland
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.22
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] NKG2D is the main receptor involved in NK cell activation against NKG2D ligand-positive melanoma cell lines
    Morgado, S.
    Sanchez-Correa, B.
    Casado, J. G.
    Gordillo, J.
    Gayoso, I.
    Duran, M. E.
    Solana, R.
    Tarazona, R.
    IMMUNOLOGY, 2012, 137 : 242 - 242
  • [42] Development of multiomics approaches to evaluate NKG2D ligand dynamics and anti-tumor immune responses during CAR-NK treatment.
    Hansen, Kyle
    Sahu, Sombeet
    Duong, Bao
    Cho, Cynthia
    Zhang, Qi
    Trager, James
    Tan, Joanne
    CANCER RESEARCH, 2022, 82 (12)
  • [43] THE SIDE-EFFECTS OF ANTI-TUMOR CHEMOTHERAPY
    GHIONE, M
    MINERVA MEDICA, 1980, 71 (15) : 1095 - 1099
  • [44] Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell-based therapeutic approaches
    Chitadze, Guranda
    Kabelitz, Dieter
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 96 (02)
  • [45] NKG2D receptor stimulation of effector CD8+T cells alters the transcriptome and activation of mTOR to enhance anti-tumor immunity
    Trace, Kelsey
    Jacobson, Sara
    Barber, Amorette E.
    CANCER RESEARCH, 2015, 75
  • [46] INVESTIGATION OF THE ANTI-TUMOR EFFECTS OF BEVACIZUMAB ON GLIOBLASTOMA CELLS
    Hasimoglu, Zeynep
    Erbayraktar, Zubeyde
    Erbayraktar, Resat Serhat
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2021, 5 (02): : 110 - 114
  • [47] Resveratrol Enhances NKG2D-Mediated Cytotoxicity Against Leukemia Cells by Upregulating Both NKG2D Receptor on NK Cells As Well As NKG2D Ligands on Target Cells
    Espinoza, Luis J.
    Takami, Akiyoshi
    Nakata, Katsuya
    Ly Quoc Trung
    Yamada, Kayoko
    Touda, Saki
    Nakao, Shinji
    BLOOD, 2011, 118 (21) : 1395 - 1395
  • [48] The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
    Kong, Yan
    Cao, Wei
    Xi, Xueyan
    Ma, Chi
    Cui, Lianxian
    He, Wei
    BLOOD, 2009, 114 (02) : 310 - 317
  • [49] Synergistic Anti-Tumor Effects of Zoledronic Acid and Radiotherapy against Metastatic Hepatocellular Carcinoma
    Morii, Kazuhiko
    Aoyama, Yuhki
    Nakamura, Shinichiro
    Okushin, Hiroaki
    INTERNAL MEDICINE, 2015, 54 (20) : 2609 - 2613
  • [50] Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells
    A El-Gazzar
    X Cai
    R S Reeves
    Z Dai
    A Caballero-Benitez
    D L McDonald
    J Vazquez
    T A Gooley
    G E Sale
    T Spies
    V Groh
    Oncogene, 2014, 33 : 4932 - 4940
12345